Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies
Authors
Keywords
Neoantigens, Cancer vaccines, Genomic profiling, Poly-epitope
Journal
Genome Medicine
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-02-15
DOI
10.1186/s13073-017-0408-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
- (2016) J. He et al. BLOOD
- Neoantigen: A Long March toward Cancer Immunotherapy
- (2016) Y. Liu CLINICAL CANCER RESEARCH
- Identification of Individual Cancer-Specific Somatic Mutations for Neoantigen-Based Immunotherapy of Lung Cancer
- (2016) Takahiro Karasaki et al. Journal of Thoracic Oncology
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Cancer immunotherapy targeting neoantigens
- (2016) Yong-Chen Lu et al. SEMINARS IN IMMUNOLOGY
- The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine
- (2016) Andrea Garofalo et al. Genome Medicine
- Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation
- (2015) M. Leisegang et al. CLINICAL CANCER RESEARCH
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- OptiType: precision HLA typing from next-generation sequencing data
- (2014) András Szolek et al. BIOINFORMATICS
- Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations
- (2014) Faviel F. González-Galarza et al. NUCLEIC ACIDS RESEARCH
- HLA Class I Alleles Are Associated with Peptide-Binding Repertoires of Different Size, Affinity, and Immunogenicity
- (2013) S. Paul et al. JOURNAL OF IMMUNOLOGY
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- (2013) Garrett M Frampton et al. NATURE BIOTECHNOLOGY
- Peptide binding predictions for HLA DR, DP and DQ molecules
- (2010) Peng Wang et al. BMC BIOINFORMATICS
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach
- (2008) Peng Wang et al. PLoS Computational Biology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started